Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval

By Padmanabhan Ananthan Aug 26 (Reuters) – The U.S. FDA has approved Revolution Medicines' groundbreaking pancreatic cancer drug after it was shown to double the survival rate of patients with

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)